These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 9476114)

  • 1. Controlling the complement system in inflammation.
    Kirschfink M
    Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting complement in therapy.
    Kirschfink M
    Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The complement system: an old story or target of new therapeutic approaches?].
    Heller A; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Apr; 35(4):207-13. PubMed ID: 10830072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].
    Kirschfink M; Haferkamp A; Pomer S; Chrupcala M; Wosnik A; Heckl-Ostreicher B
    Zentralbl Chir; 1998; 123(7):793-7. PubMed ID: 9746977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic inhibition of the complement system. Y2K update.
    Asghar SS; Pasch MC
    Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy].
    Kirschfink M
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1087-90. PubMed ID: 7641591
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of complement and perspectives for intervention in ischemia-reperfusion damage.
    Banz Y; Rieben R
    Ann Med; 2012 May; 44(3):205-17. PubMed ID: 21254897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibitors in myocardial ischemia/reperfusion injury.
    Lucchesi BR; Kilgore KS
    Immunopharmacology; 1997 Dec; 38(1-2):27-42. PubMed ID: 9476112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic regulation of the complement system in acute injury states.
    Moore FD
    Adv Immunol; 1994; 56():267-99. PubMed ID: 8073948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement receptors in shock and transplantation.
    Deitch EA; Mancini MC
    Arch Surg; 1993 Nov; 128(11):1222-6. PubMed ID: 8239984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of complement and perspectives for intervention in transplantation.
    Chen G; Chen S; Chen X
    Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application.
    Kirschfink M; Nürnberger W
    Mol Immunol; 1999; 36(4-5):225-32. PubMed ID: 10403475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1. Analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection.
    Heckl-Ostreicher B; Wosnik A; Kirschfink M
    Transplantation; 1996 Dec; 62(11):1693-6. PubMed ID: 8970634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP-10 (AVANT Immunotherapeutics).
    Rioux P
    Curr Opin Investig Drugs; 2001 Mar; 2(3):364-71. PubMed ID: 11575706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hyperacute transplant rejection by soluble proteins with the functional domains of CD46 and FcgammaRII.
    Lanteri MB; Powell MS; Christiansen D; Li YQ; Hogarth M; Sandrin MS; Mckenzie IF; Loveland BE
    Transplantation; 2000 Mar; 69(6):1128-36. PubMed ID: 10762218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sCR1sLe ameliorates ischemia/reperfusion injury in experimental lung transplantation.
    Stammberger U; Hamacher J; Hillinger S; Schmid RA
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1078-84. PubMed ID: 11088029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic complement inhibition: new developments.
    Emlen W; Li W; Kirschfink M
    Semin Thromb Hemost; 2010 Sep; 36(6):660-8. PubMed ID: 20865643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in heart diseases. Role of oxidants.
    Chakraborti T; Mandal A; Mandal M; Das S; Chakraborti S
    Cell Signal; 2000 Oct; 12(9-10):607-17. PubMed ID: 11080612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.
    Pratt JR; Hibbs MJ; Laver AJ; Smith RA; Sacks SH
    Am J Pathol; 1996 Dec; 149(6):2055-66. PubMed ID: 8952538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylatoxins: their role in bacterial infection and inflammation.
    Haas PJ; van Strijp J
    Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.